Learn More
Medchemexpress LLC Orantinib | 252916-29-3 | 98.5% | 310.35 | C18H18N2O3 | 5 MG

Supplier: Medchemexpress LLC HY105175MG
Orantinib (SU6668; TSU-68) is a small-molecule, multi-targeted receptor tyrosine kinase inhibitor used in preclinical research. It inhibits VEGFR (Flt-1), PDGFRβ, and FGFR1 with reported Kis of 2.1 μM, 8 nM, and 1.2 μM, respectively. The compound has molecular formula C18H18N2O3, molecular weight 310.35, CAS 252916-29-3, and is provided as a purified research reagent.
- Inhibits VEGFR (Flt-1), PDGFRβ, and FGFR1 with documented Ki values.
- Exhibits antiangiogenic and antitumor activity in preclinical studies.
- Supplied as a purified research-grade small molecule with reported purity around 98.5%.
- Available in multiple sizes suitable for assay development and in vivo dosing studies.
- Suitable for target validation, pathway studies, and pharmacology experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.